Contaminated blood
sufferers with hepatitis C benefit from new payment scheme
The support
offered to individuals who contracted hepatitis C in England from
NHS blood and blood products in the late1970s and 1980s is to be
substantially increased, Health Secretary Andrew Lansley announced
today following a three-month review.
The Government announced in October 2010 that they would be
reviewing the financial and other support available to those
affected. The review report has been published today together with
a new package of financial support to those infected with
hepatitis C.
To date, almost 4,300 people who were infected through their
treatment have received payments. The review examined the clinical
evidence for further support for these individuals, and also
considered how best to provide support for families of those affected.
Currently, anyone with chronic hepatitis C contracted from
contaminated blood receives a one-off payment of £20,000. A
further £25,000 is paid if the disease progresses to more severe
disease such as cirrhosis or liver cancer.
The new measures outlined by the Coalition Government for those
with severe infection include:
introducing an annual payment of £12,800, for those with the
most serious hepatitis C-related disease from NHS blood
transfusions and blood products, in line with that received by
those infected with HIV;increasing the one-off payment already
made to those with the most serious hepatitis C-related disease
from £25,000 to £50,000;making discretionary payments for those
most in need; andincreasing the annual payments for both hepatitis
C and HIV in line with the Consumer Price Index.
At present no payment can be made in respect of those with
hepatitis C contracted from contaminated blood who passed away
before the Skipton Fund was established.
This will now change and a posthumous claim can now be made on
behalf of those who died prior to 29 August 2003. Payments will be
made to the individual’s estate helping more families of those
affected get financial support. This corrects an anomaly that has
existed since the scheme was set up.
Other measures will also be introduced in England to make it
easier and fairer for those affected by hepatitis C and HIV from
contaminated blood to get broader support. Measures include:
exempting these new payments from means-testing for social care
services;providing the cost of an annual prescription pre-payment
certificate to cover the cost of prescriptions for those who are
not otherwise exempt from charging; and providing £100,000 a year
for the next three years to selected national charities for
counselling services for those affected.
Mr Lansley said:
“I fully recognise that the unintended and tragic consequences of
these treatments have seriously impaired the lives of many people,
together with those of their families.
“For too long those people infected with hepatitis C have
received different support to those infected with HIV. We now
intend to make the financial support for hepatitis C patients
fairer and more comparable to the arrangements for those infected
with HIV.
“We have listened carefully to the views of the families and
campaigners themselves and I believe that changing the payment
structure in England and offering the further assistance we have
will improve the lives of these people and their families.”
Notes to Editors
For Further enquiries please contact the DH Newsdesk on 0207 210
5221.
Copies of the Review can be downloaded here:
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123363
There will now be a three month window for dependants to make
claims on behalf of loved ones who have passed away. Anyone with
hepatitis C who may be eligible under the new arrangements can
find out more about what they need to do by contacting the Skipton
Fund:
· online at: http://www.skiptonfund.org/Eng/index.html
· by email: apply@skiptonfund.org
· by phone: 020 7808 1160.
The Skipton Fund was set up in 2003 as a company limited by
guarantee.
The principal activity of the company is to implement and manage
the UK-wide ex gratia payments scheme for people infected with
Hepatitis C from NHS treatment with blood, blood products or
tissue.
The company acts as agent for the Department of Health, which in
turn acts for the health departments of the devolved
administrations.
Contacts:
Department of Health
Phone: 020 7210 5221
NDS.DH@coi.gsi.gov.uk